Original language | English |
---|---|
DOIs | |
Publication status | Published - Sept 2022 |
152 AttackMS natalizumab for the treatment of people with inflammatory demyeli- nation suggestive of multiple sclerosis
K Schmierer, I Redha, V Hammond, D Baker, F Barkhof, R Hooper, W Rashid, V Singh-Curry, J Hobart, G Giovannoni
Research output: Contribution to conference › Conference paper (not formally published) › peer-review